Topics | RaQualia Pharma Inc.

Home
Topics
RaQualia President will present at the BioCentury "NewsMakers" in the Biotech Industry Conference

RaQualia President will present at
the BioCentury "NewsMakers" in the Biotech Industry Conference

RaQualia Pharma Inc. today announced that Dr. Atsushi Nagahisa, President & CEO, will present at the BioCentury NewsMakers in the Biotech Industry Conference on October 21, 2011 at 9:00 AM (Eastern time) in New York City. The presentation will be webcast and can be accessed by the following URL.

Webcast URL: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=4579.OS&item_id=4209595

####

Topics

Corporate Information: CEO Message; Company Overview; Vision, Management Principle and Culture; Corporate Governance; Business Model; Origins of Our Corporate Name and Logo; Facilities; Access; Press Release
Research & Development: Collaboration; Partnering in Research; What are Research Tools?; Research Tool Licensing

Product Information: Anidulafungin; Ziprasidone; Dalbavancin; EP₄ Antagonist; Cyclooxygenase-2 (COX-2) Inhibitor; Ghrelin Receptor Agonist; 5-HT₄ Partial Agonist; Acid Pump Antagonist; 5-HT_2B Antagonist; CB₂ Agonist; Motilin Receptor Agonist; Licensing

Shareholder and Investor Information

To our Shareholders and Investors

Vision, Management Principle and Culture

Corporate Governance

Outline of Securities Matters

IR Related News

Understanding RaQualia Pharma! RaQualia FAQ: RaQualia's History; What does RaQualia Pharma do?; How Does RaQualia Earn Revenues?; What About Dividends?; What are RaQualia's strengths?; What Does the Future Hold for RaQualia Pharma?

Corporate Introduction Video
Contributions to Society: Corporate Contributions; Contributions to the Community; Press Release; Topics